While market analysts maintain divergent views on Inspire Medical Systems, a significant institutional investor has placed a substantial vote of...

The once-bright growth narrative for telehealth provider Hims & Hers is showing significant cracks. Market experts are now raising fundamental...

Recent regulatory filings reveal a split in institutional sentiment toward Trustmark Corporation (TRMK) shares during Q1. While Vanguard Group Inc....

Ligand Pharmaceuticals is set to enhance its communication with the investment community through a series of high-profile engagements this September....

Kraft Heinz investors are currently navigating a perplexing market scenario where strong business fundamentals clash with concerning technical indicators. The...

Logistics giant Matson has delivered a complex set of figures for its most recent quarter. While the company experienced a...

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Aldeyra Therapeutics' investigational drug, ADX-2191, marking a...

Medical device innovator AtriCure has delivered a powerful second-quarter performance for 2025, significantly exceeding market expectations. The company not only...

The proposed acquisition of Y-mAbs Therapeutics by SERB Pharmaceuticals has encountered unexpected turbulence, shifting from a seemingly concluded transaction to...

In a notable departure from conventional market practice, real estate investment trust NexPoint Residential has secured a secondary listing. The...